Preparation method of gel

By extracting and isolating the sodium channel blocker in yogurt and combining it with chitosan and preparing it into gel dressing, the problem of difficult to effectively extract and apply yogurt alkaloids in the prior art is solved, and the firing is achieved Effective analgesic effects of scalds.

CN118986986APending Publication Date: 2024-11-22HUNAN BARD MEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411098777.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-07-18
Filing Date
2024-08-12
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to effectively extract analgesic alkaloids from yrassocks, and it is difficult to apply them to burn-scald gels to relieve pain.

Method used

The rosa was pulverized by drying and pulverizing, extracted using organic solvent reflux and extracted, separated and purified by macroporous resin, and separated by high-performance liquid chromatography to obtain a sodium channel blocker, which was combined with chitosan and other materials to prepare into a gel dressing.

Benefits of technology

A highly effective analgesic dressing is achieved by extracting sodium channel blockers with strong analgesic effects from yarcosa and effectively alleviating the pain of burns and scalds through the gel form.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118986986A_ABST
    Figure CN118986986A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of gel. The invention provides a sodium channel blocker which is extracted from rhizoma corydalis. The preparation method comprises the following steps: drying and crushing rhizoma corydalis, performing reflux extraction by using an organic solvent, taking an extracting solution, removing the organic solvent in the extracting solution, performing extraction, and performing separation and purification by using macroporous resin; finally, removing impurities, collecting eluent, and concentrating under reduced pressure to obtain extract; and eluting the extract by adopting preparative high performance liquid chromatography to obtain the compound. The sodium channel blocker can inhibit Nav1.7 and Nav1.8, so that the sodium channel blocker has an analgesic effect. When being used for preparing the burn and scald gel, the compound has a relatively good analgesic effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of burn and scald gel, and particularly relates to a sodium channel blocker for relieving the pain of burn and scald, an extraction method thereof, and a gel comprising the sodium channel blocker. Background Art

[0003] For hundreds of years, Yanhusuo has been used in Chinese medicine for pain relief. It is the dried tuber of the poppy family plant Yanhusuo, from which a variety of alkaloids can be isolated, including various alkaloids such as various yanhusuo amines, yanhusuo amines and yanhusuo amines. The analgesic mechanism of Yanhusuo is complex and delicate, involving inhibiting the release of inflammatory factors, regulating nerve conduction, promoting the release of endorphins, and improving blood circulation. The active ingredients in Yanhusuo can inhibit the release of inflammatory factors in the body, such as prostaglandins and interleukins. By reducing the production of inflammatory factors, Yanhusuo can reduce the pain response caused by tissue damage. Yanhusuo has a regulatory effect on the central nervous system, can reduce the excitability of neurons, and reduce the conduction of pain signals. Yanhusuo can promote the release of endorphins, thereby enhancing the analgesic effect. Some components in Yanhusuo can directly inhibit the conduction of pain signals, such as inhibiting NMDA receptors. Yanhusuo can increase coronary flow and cerebral blood flow, reduce myocardial oxygen consumption, improve hypoxia tolerance, help improve blood circulation in tissues and organs, and relieve pain caused by ischemia and hypoxia.

[0004] Therefore, isolating alkaloids from Corydalis yanhusuo that can be used for better analgesia has become an unresolved problem in the field of traditional Chinese medicine pharmacology. Summary of the invention

[0005] The first object of the present invention is to provide a sodium channel blocker.

[0006] The second object of the present invention is to provide a method for extracting the sodium channel blocker.

[0007] The third object of the present invention is to provide a burn and scald gel containing the sodium channel blocker.

[0008] The fourth object of the present invention is to provide a method for preparing the sodium channel blocker burn gel.

[0009] The present invention is achieved through the following technical solutions: A sodium channel blocker, the structure of the sodium channel blocker is as follows: .

[0010] The method for extracting the sodium channel blocker comprises the following steps: Dried and crushed Corydalis yanhusuo, then extracted with an organic solvent by refluxing, and then the extract was taken, and the organic solvent in the extract was removed and then extracted, and separated and purified with a macroporous resin; finally, impurities were removed, and the eluate with 50% ethanol was collected and concentrated under reduced pressure to obtain an extract; the extract was eluted with preparative high performance liquid chromatography, and the substance with a retention time of 20-22min was collected to obtain.

[0011] The organic solvent includes ethanol The mobile phase used in the high performance liquid chromatography is acetonitrile-0.1% formic acid aqueous solution.

[0012] The gradient elution procedure used in the HPLC is as follows: 0~5min, 5%A; 5-24min, 5%-25%A; 24-35min, 25% A; 35-40min, 30% A; 40~50min, 35%~45%A; 50~55min, 45%~60%A; 55~65min, 75%~90%A; 65~75min, 95%A.

[0013] The column temperature used in the HPLC was 25°C and the volume flow rate was 1.5 mL min -1 , the injection volume was 5 μL.

[0014] A gel comprises 5-10 parts of chitosan or its derivatives, 0.5-0.7 parts of the sodium channel blocker as claimed in claim 1, 5-8 parts of a thickener, 5-25 parts of a moisturizer and 48-98 parts of water.

[0015] The chitosan derivative is selected from one of carboxymethyl chitosan, isobutyl chitosan, hydroxypropyl chitosan and hyaluronic acid chitosan; The molecular weight of the chitosan or chitosan derivative is 100,000 to 1,000,000; The moisturizing agent is selected from at least one of glycerin, propylene glycol, mannitol, butylene glycol and sorbitol; The thickener includes etherified hydroxyethyl cellulose.

[0016] The preparation method of the gel comprises the following steps Chitosan or its derivative is dissolved in 1% glacial acetic acid solution, then a thickener and a moisturizer are added, and the mixture is allowed to swell overnight to obtain a gel; a sodium channel blocker is then added to the gel, and the mixture is stirred and mixed uniformly; finally, a pH value of the gel is adjusted to 4-7 with a pH regulator, and water is added to obtain the gel.

[0017] The pH regulator is an acid or a base, wherein the acid is selected from one of hydrochloric acid, acetic acid, sulfuric acid, boric acid, lactic acid, citric acid, tartaric acid, acetic acid and malic acid, and the base is selected from one of sodium hydroxide, sodium carbonate, sodium citrate and triethanolamine.

[0018] Compared with the prior art, the present invention has the following beneficial effects: The present invention provides a sodium channel inhibitor, which can act on Na v1.7 and Na v1. 8, Therefore, it has a strong analgesic effect.

[0019] The sodium channel inhibitor provided by the invention can be extracted from Corydalis yanhusuo, the raw materials used for extraction are from a wide range of sources, and the extraction method is simple.

[0020] The chitosan gel provided by the present invention can effectively maintain a moist environment for wounds and relieve wound pain. The dressing uses chitosan polymer materials as a matrix and is supplemented with analgesics to achieve the effects of moisture absorption and moisturizing as well as the analgesic effect of analgesics. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Shows the record Na v1.7 Spectrum of cell membrane current when current is applied; Figure 2 Shows the record Na v1.8 Graph of cell membrane current when electric current is applied. DETAILED DESCRIPTION

[0022] Corydalis yanhusuo is a perennial herbaceous plant of the genus Corydalis in the family Papaveraceae, and its tubers can be used as medicine. Corydalis yanhusuo is recorded in the Kaibao Materia Medica. It is warm in nature, bitter in taste, and is good for the human heart, spleen, liver, and lungs. It is a wonderful product for promoting blood circulation, removing blood stasis, promoting qi, and relieving pain. It is especially famous for its analgesic effect. Since some alkaloids in Corydalis yanhusuo can produce analgesic effects, the present invention separates the alkaloid compounds in Corydalis yanhusuo to find out the specific extracts that can produce analgesic effects.

[0023] Specifically, the present invention firstly extracts alkaloid compounds from Corydalis yanhusuo, identifies the extracted alkaloid compounds, and identifies the alkaloids with analgesic effects by testing the ion channel inhibitory activity of the compounds.

[0024] Specifically, the extraction process is as follows: Take a certain amount of Corydalis yanhusuo, dry it and then grind it, then use 95% ethanol to reflux and extract it for 3 times, each time for 2 hours; combine the extracts, and reduce the pressure and concentrate the extracts until there is no alcohol taste, then extract with ethyl acetate to remove the fat-soluble components in the extract, and separate and purify the raffinate with macroporous resin; finally, elute the raffinate with pure water and 15% ethanol to remove impurities, and collect the 50% ethanol eluate and reduce the pressure and concentrate to obtain the extract.

[0025] The inventors used gel column and preparative high performance liquid chromatography to separate the compounds extracted from the above-mentioned Corydalis yanhusuo to obtain various extracts. The specific parameters of the preparative high performance liquid chromatography used are as follows: Chromatographic column: Inert Sustain-C18 (4.6×250μM, 5μm), mobile phase: methanol (A)-0.1% aqueous solution (B). Ultrasonic degassing before use, filtered through a 0.23μm microporous membrane.

[0026] Gradient elution program: 0~5min, 5%A; 5-15min, 5%-15%A; 15~20min, 15%~25%A; 20-27min, 25% A; 27~40min, 28%~40%A; 40~44min, 40%~50%A; 44~45min, 50%~60%A; 45~48min, 60%~75%A; 48~58min, 75%~85%A; 58~60min, 85%~95%A; 60-70min, 95% A; The column temperature was 25 °C and the volume flow rate was 1.0 mL min -1 , injection volume 5μL.

[0027] The detection wavelength was 254 nm. The mass spectrometry detection conditions were as follows: electrospray ionization (ESI) was used for ionization and negative ion mode was used for collection. The drying gas temperature was 325 °C. The drying gas volume flow rate was 7.5 L·min -1 ; sheath gas temperature was 350°C; capillary voltage was 4.0 kV; fragmentation voltage was 110 V, and the mass number range was m / z 50 to 1000. The mass axis was calibrated using the tuning solution m / z 70-3200 provided by the manufacturer.

[0028] The invention adopts gel column and preparative high performance liquid chromatography to separate the extract extracted from the Corydalis yanhusuo to obtain various compounds.

[0029] The specific parameters of the preparative HPLC used are as follows: Chromatographic column: Inert Sustain-C18 (4.6×250μM, 5μm), mobile phase: acetonitrile (A)-0.1% formic acid aqueous solution (B). Ultrasonic degassing before use, filtered with a 0.22μm microporous membrane.

[0030] The gradient elution program is as follows: 0~5min, 5%A; 5-24min, 5%-25%A; 24-35min, 25% A; 35-40min, 30% A; 40~50min, 35%~45%A; 50~55min, 45%~60%A; 55~65min, 75%~90%A; 65-75min, 95% A; The column temperature was 25 °C and the volume flow rate was 1.5 mL min -1 , injection volume 5μL.

[0031] After separating the extract by the above-mentioned preparative high performance liquid chromatography, the inventor obtained a substance with a retention time of 20-22 minutes. The Pop data of the substance with a retention time of 20-22 minutes are summarized as follows: 1H NMR (300MHz, CD3CN, δ, ppm): 9.34(1H in amide), 8.18(1H in amide), 7.31-7.23(5H in benzene), 5.77-5.72(2H in tetrahydropyridine), 4.52(1H in ethylene), 4.24(1H in methylene),4.2(1H in amine), 3.87(2H in methylene),3.58(1H in tetrahydropyridine), 3.46(1H in methine), 2.85(1H in tetrahydropyridine), 2.77-2.35(5H in methylene),2.13(1H in tetrahydropyridine), 2.09(1H in methylene), 1.92(3H in methyl),1.88(1H in tetrahydropyridine). 13C NMR (300MHz, CD3CN, δ, ppm): 9.8, 172.9, 171.0, 146.9, 137.9, 128.5, 126.9, 126.7, 124.7, 120.8, 97.974.1, 66.1, 65.3, 60.7, 54.8, 49.8, 43.6, 33.4, 26.7, 23.4.

[0032] According to the above spectral data, the structure of the substance with a retention time of 20-22 min can be determined as follows: .

[0033] The present invention tests the ion channel inhibitory activity of the extract, and the specific test method and results are as follows: 1. Cell preparation and expression Human embryonic kidney (HEK) 293 cells were cultured in DMEM (HyClone) supplemented with 10% fetal calf serum (Gibco) and penicillin (100 units / ml), streptomycin (0.1 mg / ml) (Biological Industries). 293 cells in logarithmic growth phase were transfected with human pCDNA3.1-TRPA1, TRPV1, TRPM8, Na v1.7 、Na v1.8Plasmid transfection into cells. Transfected human embryonic kidney (HEK) 293 cells must be used within 48 hours.

[0034] 2. Electrophysiological testing All tests were performed at room temperature (22-25°C). The test equipment was a microelectrode puller (P-1000, Sutter Instrument). Borosilicate glass pipettes (World Precision Instruments) were prepared into glass electrodes with an impedance of 2-4 MΩ by heating and polishing, and the glass electrodes were used for whole-cell current recording.

[0035] The recorded current was amplified by Axopatch 200B and then converted by Digidata 1440A (Molecular Devices). The current was passed through a low-energy filter at 2 kHz and then sampled at 10 kHz. pCLAMP 10 (Molecular Devices) was used for data acquisition and analysis.

[0036] Record Na v1.7 and Na v1.8 The extracellular solution contained (in mM) 135K-gluconate, 5KCl, 5Mg-ATP, 0.5Na 2 GTP, 5HEPES, 2MgCl 2 , 5EGTA and 0.5CaCl 2 (pH = 7.4, adjusted with KOH) The intracellular solution contains (in mM) 140 NaCl, 5 KCl, 2 CaCl 2 , 2MgCl 2 , 10HEPES and 10glucose (pH = 7.4, adjusted with NaOH). The current recording procedure is: clamp the cell membrane at -110mV potential, stimulate the cell with a 10ms -30mV depolarizing voltage, and each stimulation interval is 5s. From the test results, it can be seen that compared with the control sample (no sodium channel inhibitor), the high concentration extract (the extract is dissolved in the extracellular fluid, and the concentration reaches 12μM) has a significant effect on Na v1.7 、Na v1.8 The inhibitory effect on ion channels is obvious, and the above extracts can inhibit sodium channels.

[0037] The extract provided in the present invention has an effect on Na v1.7 The half inhibition concentration IC50 is 0.88μM for Na v1.8 The half inhibition concentration IC50 is 0.90μM.

[0038] Human embryonic kidney 293T (HEK293T) cells stably expressing TRPA1, TRPM8 and TRPV1 were used to perform functional tests on the inhibitory activity of TRPA1, TRPM8 and TRPV1 proteins. In this experiment, the half-maximum inhibition concentration (IC50) of the extract provided by the present invention on TRPA1, TRPM8 and TRPV1 proteins was greater than 50 μM. This shows that the extract provided by the present invention has no significant inhibitory effect on TRPA1, TRPM8 and TRPV1 proteins at 50 μM.

[0039] The extract was prepared into a gel by the following method: The method comprises dissolving chitosan or its derivatives in 1% glacial acetic acid solution, then adding a thickener and a moisturizer, and allowing the mixture to swell overnight to obtain a gel; then adding a sodium channel blocker to the gel, stirring and mixing the mixture evenly; finally adjusting the pH value of the gel to 4 to 7 with a pH regulator, and adding purified water to obtain a chitosan gel containing a sodium channel blocker. The gel contains 5 to 10 parts of chitosan or its derivatives, 0.5 to 0.7 parts of a sodium channel blocker, 5 to 8 parts of a thickener, 5 to 25 parts of a moisturizer, and 48 to 98 parts of purified water.

[0040] Specifically, the chitosan derivative is selected from carboxymethyl chitosan, isobutyl chitosan, hydroxypropyl chitosan and hyaluronic acid chitosan. The molecular weight of the chitosan or its derivative is 100,000 to 1,000,000, preferably 300,000 to 500,000.

[0041] Specifically, the thickener is etherified hydroxyethyl cellulose. Etherified hydroxyethyl cellulose is produced by Shinetsu Chemical Co. Ltd. (Tokyo, Japan), and its model is Tylose® HS 100000YP2HEC.

[0042] Specifically, the moisturizing agent is selected from at least one of glycerin, propylene glycol, mannitol, butylene glycol and sorbitol.

[0043] Specifically, the pH adjuster is an acid or a base, wherein the acid is selected from one of hydrochloric acid, acetic acid, sulfuric acid, boric acid, lactic acid, citric acid, tartaric acid, acetic acid and malic acid, and the base is selected from one of sodium hydroxide, sodium carbonate, sodium citrate and triethanolamine.

[0044] The chitosan gel provided by the present invention is a gel dressing, wherein the water content is 80-90%, the gel dressing is translucent and non-sticky, and the gel dressing has high cohesive properties, and therefore, is often used for burns and scalds. The gel dressing is made of natural polymer materials that are non-toxic, non-antigenic, biocompatible, and biodegradable, and is suitable for promotion and application. The use of etherified hydroxyethyl cellulose reduces the turbidity of the gel and improves the water retention of the gel.

[0045] The gel is further described below in conjunction with specific examples. Example 1 5 parts of chitosan (molecular weight 100000) are dissolved in 1% glacial acetic acid solution, and then 5 parts of etherified hydroxyethyl cellulose and 6 parts of glycerol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 4 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0046] Example 2 7 parts of chitosan (molecular weight 150000) are dissolved in 1% glacial acetic acid solution, and then 6 parts of etherified hydroxyethyl cellulose and 10 parts of glycerol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 5 with hydrochloric acid and sodium hydroxide, and 60 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0047] Example 3 9 parts of carboxymethyl chitosan (molecular weight 300000) are dissolved in 1% glacial acetic acid solution, and then 7 parts of etherified hydroxyethyl cellulose and 15 parts of glycerol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.6 parts of a sodium channel blocker are added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 4 with hydrochloric acid and sodium hydroxide, and 80 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0048] Example 4 10 parts of isobutyl chitosan (molecular weight 500000) are dissolved in 1% glacial acetic acid solution, and then 8 parts of etherified hydroxyethyl cellulose and 20 parts of glycerol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.7 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 4 with hydrochloric acid and sodium hydroxide, and 70 parts of purified water are added to obtain a gel chitosan gel including a sodium channel blocker.

[0049] Example 5 5 parts of chitosan (molecular weight 1000000) are dissolved in 1% glacial acetic acid solution, and then 8 parts of etherified hydroxyethyl cellulose and 25 parts of glycerol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 4 with hydrochloric acid and sodium hydroxide, and 490 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0050] Example 6 5 parts of chitosan are dissolved in 1% glacial acetic acid solution, and then 5 parts of etherified hydroxyethyl cellulose and 20 parts of propylene glycol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 4 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0051] Example 7 7 parts of chitosan are dissolved in 1% glacial acetic acid solution, and then 7 parts of etherified hydroxyethyl cellulose and 15 parts of mannitol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 7 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0052] Example 8 9 parts of chitosan are dissolved in 1% glacial acetic acid solution, and then 6 parts of etherified hydroxyethyl cellulose and 10 parts of sorbitol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker is added to the gel, and the mixture is stirred and mixed evenly; finally, the pH value of the gel is adjusted to 6 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0053] Comparative Example 1 9 parts of chitosan were dissolved in 1% glacial acetic acid solution, and then 6 parts of etherified hydroxyethyl cellulose and 10 parts of sorbitol were added, and the mixture was allowed to swell overnight to obtain a gel; finally, the pH value of the gel was adjusted to 6 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water were added to obtain a chitosan gel without a sodium channel blocker.

[0054] Comparative Example 2 9 parts of chitosan were dissolved in 1% glacial acetic acid solution, and then 6 parts of etherified hydroxyethyl cellulose and 10 parts of sorbitol were added, and the mixture was allowed to swell overnight to obtain a gel; then 0.5 parts of lidocaine was added to the gel, and the mixture was stirred and mixed evenly; finally, the pH value of the gel was adjusted to 6 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water were added to obtain a gel chitosan gel without a sodium channel blocker.

[0055] Comparative Example 3 9 parts of chitosan are dissolved in 1% glacial acetic acid solution, and then 10 parts of sorbitol are added, and the mixture is allowed to swell overnight to obtain a gel; then 0.5 parts of a sodium channel blocker are added to the gel, and the mixture is stirred and mixed uniformly; finally, the pH value of the gel is adjusted to 6 with hydrochloric acid and sodium hydroxide, and 48 parts of purified water are added to obtain a chitosan gel containing a sodium channel blocker.

[0056] Table 1 below shows the turbidity of the gel provided in the embodiment of the present invention and the weight loss data of the gel after 6 hours. It can be seen from the table that etherified hydroxyethyl cellulose can reduce the turbidity of chitosan gel and improve its water retention.

[0057] Table 1 In order to illustrate that the gel provided by the present invention has a pain relieving effect, the present invention conducted the following tests on the gel dressing: Test method: The SPF-grade C57BL / 6 mice aged 8-10 weeks were adapted to the SPF barrier system for 3 days. First control group: the auxiliary material prepared in comparative example 1 was applied to the sole of the right hind limb of mice.

[0058] Second control group: the auxiliary material prepared in comparative example 2 was applied to the sole of the right hind limb of mice.

[0059] Test drug group: The auxiliary material prepared in Example 8 was applied to the sole of the right hind limb of the mice. Note: There were 20 animals.

[0060] Animal thermal stimulation pain sensitivity test: The mice were placed on a stainless steel hot plate (20 cm diameter round plate) at a temperature of 40°C, and the time of the first foot retraction or foot licking of the administered foot was recorded. From the above test, it can be found that the first foot retraction or foot licking time of the first control group was 88 seconds on average, the first foot retraction or foot licking time of the second control group was 158 seconds on average, and the first foot retraction or foot licking time of the test group was 256 seconds on average. From the above results, it can be seen that the gel prepared in Example 7 can reduce the thermal pain of mice and increase their pain threshold.

[0061] It should be understood that the above embodiments and the following examples described in detail in the present invention are only used to illustrate the present invention and are not used to limit the scope of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above contents of the present invention belong to the protection scope of the present invention. The specific parameters and the like in the following examples are also only examples within a suitable range, that is, those skilled in the art can make a selection within a suitable range through the description of this article, and are not limited to the specific values ​​in the following examples.

Claims

1. A sodium channel blocker, characterized in that: The structure of the sodium channel blocker is as follows: 。 2. The method for extracting a sodium channel blocker as claimed in claim 1, wherein: The steps include: Dried and crushed Corydalis yanhusuo, then extracted with an organic solvent by refluxing, and then the extract was taken, and the organic solvent in the extract was removed and then extracted, and separated and purified with a macroporous resin; finally, impurities were removed, and the eluate with 50% ethanol was collected and concentrated under reduced pressure to obtain an extract; the extract was eluted with preparative high performance liquid chromatography, and the substance with a retention time of 20-22min was collected to obtain.

3. The method for extracting a sodium channel blocker as claimed in claim 1, wherein: The organic solvent includes ethanol.

4. The method for extracting a sodium channel blocker as claimed in claim 1, wherein: The mobile phase used in the high performance liquid chromatography is acetonitrile-0.1% formic acid aqueous solution.

5. The method for extracting a sodium channel blocker as claimed in claim 1, wherein: The gradient elution procedure used in the HPLC is as follows: 0~5min, 5%A; 5-24min, 5%-25%A; 24-35min, 25% A; 35-40min, 30% A; 40~50min, 35%~45%A; 50~55min, 45%~60%A; 55~65min, 75%~90%A; 65~75min, 95%A.

6. The method for extracting a sodium channel blocker as claimed in claim 1, wherein: The column temperature used in the HPLC was 25°C and the volume flow rate was 1.5 mL min -1 , the injection volume was 5 μL.

7. A gel, characterized in that: The invention comprises 5 to 10 parts of chitosan or its derivatives, 0.5 to 0.7 parts of the sodium channel blocker as claimed in claim 1, 5 to 8 parts of a thickener, 5 to 25 parts of a moisturizing agent and 48 to 98 parts of water.

8. The gel according to claim 7, characterized in that The chitosan derivative is selected from one of carboxymethyl chitosan, isobutyl chitosan, hydroxypropyl chitosan and hyaluronic acid chitosan; The molecular weight of the chitosan or chitosan derivative is 100,000 to 1,000,000; The moisturizing agent is selected from at least one of glycerin, propylene glycol, mannitol, butylene glycol and sorbitol; The thickener includes etherified hydroxyethyl cellulose.

9. The method for preparing the gel according to claim 7, characterized in that: The following steps are included Chitosan or its derivative is dissolved in 1% glacial acetic acid solution, then a thickener and a moisturizer are added, and the mixture is allowed to swell overnight to obtain a gel; a sodium channel blocker is then added to the gel, and the mixture is stirred and mixed uniformly; finally, a pH value of the gel is adjusted to 4-7 with a pH regulator, and water is added to obtain the gel.

10. The method for preparing the gel according to claim 7, characterized in that: The pH regulator is an acid or a base, wherein the acid is selected from one of hydrochloric acid, acetic acid, sulfuric acid, boric acid, lactic acid, citric acid, tartaric acid, acetic acid and malic acid, and the base is selected from one of sodium hydroxide, sodium carbonate, sodium citrate and triethanolamine.